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See article by Fraser et al. [43] (pages 111 –118) in demonstrated that ‘neuronal NOS’(NOS1) [18], ‘macro-
this issue. phage NOS’ (NOS2) [19], and ‘endothelial cell NOS’
(NOS3) [20] or splice variants of the respective enzymes
The mechanisms contributing to sex differences in are expressed in a variety of tissues [26–29], including
susceptibility to and mortality from cardiovascular and macrophages [19], kidney, [27,30] skeletal muscle [28],
renal disease are still unknown. Sexual dimorphisms of and myocardium [31,32]. The terminology formerly used
coronary artery disease were first suggested by Heberden to indicate calcium-dependency has also been abandoned
in 1802 [1], and researchers have described vascular as NOS3 also exhibits calcium-independent activity under
actions of estrogens since the late 19th century [2–4]. certain conditions [33–35]. In addition, induction of
Subsequently, several studies provided indirect and direct ‘constitutive’ isoforms has been observed (i.e. induction of
evidence for an involvement of estrogens in the regulation NOS3 by estrogen) [20,36], and the ‘inducible’ isoform
of vascular tone [5–9]. Most of the mechanisms were only NOS2 is constitutively expressed in certain organs (i.e. the
?discovered in the past two decades (reviewed in Refs. kidney) [27,30]. Interestingly, inhibition of NO synthases
[10,11]), following the observation by Furchgott and may exert detrimental as well as beneficial effects on tissue
Zawadzki that vascular smooth muscle tone is regulated by and organ injury [25,37], which may be related to differen-
an endothelium-derived relaxing factor [12], later iden- tial generation of NOS-derived free radicals [21–24].
?tified as the free radical nitric oxide ( NO) [13]. A number Reperfusion injury is a complex event altering intracel-
of studies suggested protective effects of estrogen on lular homeostasis, cardiomyocyte function, and elec-
atherosclerosis and related diseases [14,15], and multiple tromechanical properties of the ischemic and post-ischemic
actions of estrogens on vascular homeostasis including myocardium. Increased oxidative stress as a consequence
modulation of vascular enzymes [16], vasoactive proteins of ischemia–reperfusion is considered an important factor
?
and NO were subsequently identified (reviewed in Refs. contributing to these abnormalities, as administration of
[10,11,17]). free-radical scavengers attenuates reperfusion injury
?NO is a labile gas formed by multi-enzyme complexes, [37,38]. Calcium-independent NOS2 contributes to
?the NO synthases (NOSs) [18–20]. However, these en- myocardial injury in vitro [39] and has been recently
?
zymes not only catalyze the generation of NO from implicated in myocardial dysfunction, reperfusion injury
L-arginine, but also contribute to the formation of superox- and apoptosis in vivo [40,41]. On the other hand, NOS2
? 2 ?ide anion ( O ), which reacts with NO at a diffusion- participates in the protective effects of ischemic precondi-2
limited rate to form the potent oxidant peroxynitrite tioning [31,42]. The relative contribution of NOS2-derived
2 ? ? 2 2 ? 2(ONOO ) [21–24]. Accordingly, NOSs have been impli- NO, O , ONOO , or nitroxyl anion ( NO ) [38] to these2
cated in cardiovascular diseases such as hypertension, differential effects remains to be determined.
atherosclerosis, and heart failure [25]. Three major NOS Using the Langendorff model, Fraser et al. now report
isoforms have been identified [20]. Initially, NOS isoform that 17b-estradiol, a natural estrogen with vasodilating
expression was throught to be cell- /organ-specific and properties [10], increases the activity of calcium-indepen-
?isoforms were termed accordingly. Meanwhile, it has been dent but not calcium-dependent NO synthase in left
ventricular myocardium after ischemia and reperfusion in
ovarectomized rats as measured by the citrulline assay*Tel.: 141-1-255-1111, ext. 163105; fax: 141-1-255-4401.
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protein expression and accompanied by increased myocar- duction [60]. Whether, and by what mechanisms, estrogen
dial cyclic guanosine monophosphate content and im- replacement therapy also contributes to myocardial protec-
proved recovery of left ventricular function after ischemia tion in postmenopausal women as suggested by the initial
as compared to untreated controls. These observations are observation that women have less angina pectoris than
important and point to novel modes of action by which similarly aged men made by Heberden 200 years ago [1]
estrogens may improve myocardial function in postis- and whether these effects are antagonized by certain
chemic myocardium. progestogens [53,61] requires further study.
The findings of Fraser et al. are in contrast with previous
studies reporting no effects of 17b-estradiol on calcium-
independent NOS activity, but increased calcium-depen-
Acknowledgementsdent NOS activity as well as expression of NOS1 and
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